Lorena Alba‐Castellón
- Oncology top 10%
- Cancer Cells and Metastasis 6
- Chemokine receptors and signaling 3
-
- Immunotherapy and Immune Responses 9
- Toxin Mechanisms and Immunotoxins 5
-
- Glycosylation and Glycoproteins Research 3
- RNA Interference and Gene Delivery 3
-
- Cancer Research and Treatments 5
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Antonio Garcı́a de HerrerosEsther VázquezUgutz UnzuetaRamón ManguesAntonio VillaverdeIsolda CasanovaPatricia ÁlamoNaroa Serna
- Cited by
- OncologyImmunologyMolecular Biology
- Journals
- Acta Biomaterialia (3 papers)Biomedicine & Pharmacotherapy (2 papers)International Journal of Nanomedicine (2 papers)
- Partner nations
- SpainArgentinaUnited Kingdom
In The Last Decade
Lorena Alba‐Castellón
28 papers receiving 702 citations
Peers
Comparison fields: 5 of 68
- Oncology 245
- Immunology 181
- Molecular Biology 426
- Cancer Research 90
- Biotechnology 41
Countries citing papers authored by Lorena Alba‐Castellón
This map shows the geographic impact of Lorena Alba‐Castellón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorena Alba‐Castellón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorena Alba‐Castellón more than expected).
Fields of papers citing papers by Lorena Alba‐Castellón
This network shows the impact of papers produced by Lorena Alba‐Castellón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorena Alba‐Castellón. The network helps show where Lorena Alba‐Castellón may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lorena Alba‐Castellón, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 9 | |
| 8 | 2022 | 11 | |
| 9 | 2022 | 38 | |
| 10 | 2022 | 8 | |
| 11 | 2021 | 26 | |
| 12 | 2021 | 20 | |
| 13 | 2021 | 21 | |
| 14 | 2020 | 52 | |
| 15 | 2020 | 26 | |
| 16 | 2020 | 51 | |
| 17 | 2020 | 17 | |
| 18 | 2016 | 69 | |
| 19 | 2014 | 104 | |
| 20 | 2012 | 22 |
About Lorena Alba‐Castellón
Lorena Alba‐Castellón is a scholar working on Immunology, Biotechnology and Oncology, having authored 30 papers that have together received 703 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), Cancer Cells and Metastasis (6 papers), Cancer Research and Treatments (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Toxin Mechanisms and Immunotoxins (5 papers), Glycosylation and Glycoproteins Research (3 papers), RNA Interference and Gene Delivery (3 papers) and Chemokine receptors and signaling (3 papers). The work is most often cited by research in Oncology (245 citations), Immunology (181 citations) and Molecular Biology (426 citations). Lorena Alba‐Castellón has collaborated with scholars based in Spain, Argentina and United Kingdom. Frequent co-authors include Antonio Garcı́a de Herreros, Esther Vázquez, Ugutz Unzueta, Ramón Mangues, Antonio Villaverde, Isolda Casanova, Patricia Álamo, Naroa Serna, Mireia Duñach and Alberto Gallardo. Their work appears in journals such as Acta Biomaterialia, Biomedicine & Pharmacotherapy, International Journal of Nanomedicine, Journal of Controlled Release and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.